|
À̴ϽºÆ®¹ÙÀÌ¿ÀÁ¦¾à(ÁÖ) |
¿À¼Û°øÀå Ç°Áú°æ¿µ½Ç Ç°Áú°ü¸®ÆÀ ÆÀÀå ä¿ë
ÃæºÏ ûÁֽà Èï´ö±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
11.10 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Field medical, Dupilumab (Medical manage
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
10.17 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Field medical, Dupilumab (Medical manage
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
10.18 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Field medical, Dupilumab (Medical manage
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
10.21 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Field medical, Dupilumab (Medical manage
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
10.28 |
|
|
(ÁÖ)¿¤¾ØÄÉÀ̹ÙÀÌ¿À¸Þµå |
¿¤¾ØÄÉÀ̹ÙÀÌ¿À¸Þµå (ÄÚ½º´Ú)ÀÇ·á±â±â Áö½ÄÀç»ê±Ç °æ·Â ä¿ë
¼¿ï ¾çõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ç¹«/Ãѹ«/¹ý¹«/ƯÇã |
10³â¡è |
ä¿ë½Ã |
03.17 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
12.20 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
01.02 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
01.06 |
|
|
(ÁÖ)Äɾî»çÀ̵å |
(ÁÖ)Äɾî»çÀ̵å [Á¦¾à/¹ÙÀÌ¿À] Ãà»ê¸¶ÄÉÆÃÆÀ ÆÀÀå ä¿ë (Á¤
°æ±â ¼º³²½Ã Áß¿ø±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
10³â¡è |
ä¿ë½Ã |
05.03 |
|
|
(ÁÖ)¹ÙÀÌ¿ÀÀÎÇÁ¶ó |
¿µ¾÷/¸¶ÄÉÆà º»ºÎÀå ¸ðÁý (°æ·Â 10³â ÀÌ»ó)
¼¿ï Á¾·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
10³â¡è |
ä¿ë½Ã |
12.29 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
05.26 |
|
|
(ÁÖ)¸ÞµåÆÄÅ© |
±â¼ú»ç¾÷º»ºÎ Ç°Áúº¸Áõ(QA) ÆÀÀå±Þ ä¿ë
¼¿ï ¿µµîÆ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
04.24 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
05.29 |
|
|
À̴ϽºÆ®¹ÙÀÌ¿ÀÁ¦¾à(ÁÖ) |
À̴ϽºÆ®¹ÙÀÌ¿ÀÁ¦¾à(ÁÖ) »ç¾÷°³¹ß(BD) ºÎ¹® (ÆÀÀå±Þ) ¸ðÁý
°æ±â ¿ëÀνà | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
10³â¡è |
ä¿ë½Ã |
10.05 |
|